Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: Five case studies and a literature review

NDT Plus

Volumn 1, Issue SUPPL.3, 2008, Pages

  Komaba, Hirotaka ^a   Takeda, Yoko ^a   Shin, Jeongsoo ^b   Tanaka, Reika ^c   Kakuta, Takatoshi ^c   Tominaga, Yoshihiro ^d   Fukagawa, Masafumi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Motomachi HD Clinic   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Intact PTH; N PTH; Secondary hyperparathyroidism; Single nodule; Whole PTH

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCITRIOL; CYCLIN D1; FALECALCITRIOL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADENOMA; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETIC NEPHROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DOPPLER ECHOGRAPHY; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; MALE; PARATHYROID FUNCTION; PARATHYROID GLAND; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SECONDARY HYPERPARATHYROIDISM;

EID: 48749130942     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn088     Document Type: Article

References (26)

1. Goodman WG, Juppner H, Salusky IB et al. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 2003; 63: 1-11.
2. Brown RC, Aston JP, Weeks I et al. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab 1987; 65: 407-414
3. Blind E, Schmidt-Gayk H, Scharla S et al. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab 1988; 67: 353-360
4. Brossard JH, Cloutier M, Roy L et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996; 81: 3923-3929
5. Lepage R, Roy L, Rousseau L et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998; 44: 805-809
6. Brossard JH, Cardinal H, Roy L et al. Influence of glomerular filtration rate on intact parathyroid hormone levels in renal failure patients: role of non-(1-84) PTH detected by intact PTH assays. Clin Chem 2000; 46: 697-703
7. Divieti P, John MR, Juppner H et al. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 2002; 143: 171-176
8. Langub MC, Monier-Faugere MC, Wang G et al. Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. Endocrinology 2003; 144: 1135-1138
9. John MR, Goodman WG, Gao P et al. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 1999; 84: 4287-4290
10. Gao P, Scheibel S, D'Amour P et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone (1-84): implication for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001; 16: 605-614
11. Nakanishi S, Kazama JJ, Shigematsu T et al. Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients. Am J Kidney Dis 2001; 38(Suppl 1): S172-S174
12. Inaba M, Nakatsuka K, Imanishi Y et al. Technical and clinical characterization of the Bio-PTH(1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 2004; 50: 385-390
13. Souberbielle JC, Boutten A, Carlier MC et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006; 70: 345-350
14. D'Amour P, Brossard JH, Rousseau L et al. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 2003; 49: 2037-2044
15. Rakel A, Brossard JH, Patenaude JV et al. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clin Endocrinol 2005; 62: 721-727
16. Rubin MR, Silverberg SJ, D'Amour P et al. An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1-84) is overproduced in parathyroid carcinoma. Clin Chem 2007; 53: 1470-1476
17. Tanaka M, Itoh K, Matsushita K et al. Normalization of reversed biointact-PTH(1-84)/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism. Clin Nephrol 2005; 64: 69-72
18. Arakawa T, D'Amour P, Rousseau L et al. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia. Clin J Am Soc Nephrol 2006; 1: 525-531
19. Komaba H, Takeda Y, Abe T et al. Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient. Nephrol Dial Transplant 2008; 23: 1760-1762
20. Tominaga Y, Tsuzuki T, Uchida K et al. Expression of PRAD1/cyclin D1, retinoblastoma gene products and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int 1999; 55: 1375-1383
21. Schlosser K, Sitter H, Rothmund M et al. Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 2004; 28: 583-588
22. D'Amour P, Brossard JH, Rakel A et al. Evidence that the aminoterminal composition of non-(1-84) parathyroid hormone fragments starts before position 19. Clin Chem 2005; 51: 169-176
23. D'Amour P. Circulating PTH molecular forms: what we know and what we don't. Kidney Int 2006; 70(Suppl 102): S29-S33
24. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75: 145-150
25. Rabbani SA, Kremer R, Bennett HP et al. Phosphorylation of parathyroid hormone by human and bovine parathyroid glands. J Biol Chem 1984; 259: 2949-2955
26. Tanaka M, Komaba H, Itoh K et al. The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism. NDT Plus 2008; Suppl 3: iii59-62